Intervet
A combination of inactivated, purified, concentrated, adjuvanted, tissue culture origin, Equine Herpesvirus EHV-1 and EHV-4 and Equine Influenza Virus subtypes A1 and A2 including KY 93 strain. Intervet serological data suggest cross protection against certain U.S. and European strains, including Prague 56, KY 63, KY 81 and 87, Fountainbleau 79 and Berlin 84 and 89.
For vaccination of healthy horses against respiratory disease caused by Equine Herpesvirus and Equine Influenza Virus.
For primary immunization, aseptically inject 1 mL intramuscularly. Repeat the dose in 4 to 6 weeks. A 1 mL dose should be administered annually and at any time epidemic conditions exist or are reported and exposure is imminent.
Store at 35o to 45o F (2o to 7oC). Shake well before using. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Local reactions may occur if this product is given subcutaneously. Inject deep into the muscle only. Anaphylactoid reactions may occur.
Epinephrine. Neomycin, polymyxin B, nystatin and thimerosal added as preservatives.
Intervet
P.O. Box 75612
Charlotte, NC 28275
1-800-835-0541
www.intervetusa.com
Disclaimer
Every effort has been made by Stockyards to ensure the accuracy of the information listed above. However, it remains your responsibility to become familiar with the products you are purchasing. Please consult your family veterinarian if you have any questions.
